Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Molecular and Cellular Biochemistry
|
August 18, 2011
PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway
Chun-Yan Wu, Zhi-Han Tang, Lu Jiang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 30, 2020
Role of oral microbiota in atherosclerosis
Xiang-Rui Liu, Qian Xu, Jun Xiao, et al.
Molecular and Cellular Biology
|
January 9, 2013
Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases
Yuan Zhang, Zhi-Han Tang, Zhong Ren, et al.
Acta Pharmacologica Sinica
|
May 11, 2004
Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages
Chao-ke Tang, Guang-hui Yi, Jun-hao Yang, et al.
Atherosclerosis
|
April 13, 2013
Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesis
Mi-Hua Liu, Zhi-Han Tang, Guo-Hua Li, et al.
European Journal of Pharmacology
|
February 2, 2021
Effects of gut microbiota on atherosclerosis through hydrogen sulfide
Dan-Dan Gui, Wen Luo, Bin-Jie Yan, et al.
Journal of Cellular Physiology
|
September 25, 2018
PCSK9: A novel inflammation modulator in atherosclerosis?
Zhi-Han Tang, Tao-Hua Li, Juan Peng, et al.
Frontiers in Cardiovascular Medicine
|
August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future priorities
Ye-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 21, 2018
Endothelial to mesenchymal transition in atherosclerotic vascular remodeling
Ya-Meng Hao, Hou-Qin Yuan, Zhong Ren, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 19, 2022
PCSK9: A emerging participant in heart failure
Qian Xu, Yi-Meng Zhao, Nai-Qi He, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Molecular and Cellular Biochemistry
|
August 18, 2011
PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway
Chun-Yan Wu, Zhi-Han Tang, Lu Jiang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 30, 2020
Role of oral microbiota in atherosclerosis
Xiang-Rui Liu, Qian Xu, Jun Xiao, et al.
Molecular and Cellular Biology
|
January 9, 2013
Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases
Yuan Zhang, Zhi-Han Tang, Zhong Ren, et al.
Acta Pharmacologica Sinica
|
May 11, 2004
Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages
Chao-ke Tang, Guang-hui Yi, Jun-hao Yang, et al.
Atherosclerosis
|
April 13, 2013
Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesis
Mi-Hua Liu, Zhi-Han Tang, Guo-Hua Li, et al.
European Journal of Pharmacology
|
February 2, 2021
Effects of gut microbiota on atherosclerosis through hydrogen sulfide
Dan-Dan Gui, Wen Luo, Bin-Jie Yan, et al.
Journal of Cellular Physiology
|
September 25, 2018
PCSK9: A novel inflammation modulator in atherosclerosis?
Zhi-Han Tang, Tao-Hua Li, Juan Peng, et al.
Frontiers in Cardiovascular Medicine
|
August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future priorities
Ye-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 21, 2018
Endothelial to mesenchymal transition in atherosclerotic vascular remodeling
Ya-Meng Hao, Hou-Qin Yuan, Zhong Ren, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 19, 2022
PCSK9: A emerging participant in heart failure
Qian Xu, Yi-Meng Zhao, Nai-Qi He, et al.
Page
of 4